Elocon and Ezetimibe drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Elocon (mometasone furoate) and Ezetimibe (ezetimibe). Common drug interactions include nausea among females and klebsiella infection among males.

The phase IV clinical study analyzes what interactions people have when they take Elocon and Ezetimibe. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Elocon?

Elocon has active ingredients of mometasone furoate. It is often used in eczema. eHealthMe is studying from 2,019 Elocon users. Check the latest studies of Elocon.

What is Ezetimibe?

Ezetimibe has active ingredients of ezetimibe. It is often used in high blood cholesterol. eHealthMe is studying from 30,849 Ezetimibe users. Check the latest studies of Ezetimibe.



On Jul, 20, 2026

16 people who take Elocon and Ezetimibe together, and have interactions are studied.

Elocon and Ezetimibe drug interactions.

What are the common drug interactions of Elocon and Ezetimibe, by gender? *:

female:

  1. Nausea (feeling of having an urge to vomit)
  2. Vomiting
  3. Asterixis (flapping tremor, or liver flap)
  4. Balance disorder
  5. Cross sensitivity reaction
  6. Dizziness
  7. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  8. Headache (pain in head)
  9. Memory impairment
  10. Nonspecific reaction (unspecified reaction)

male:

  1. Klebsiella infection
  2. Anaemia (lack of blood)
  3. Balance disorder
  4. Bone loss
  5. Bradycardia (abnormally slow heart action)
  6. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  7. Chronic kidney disease
  8. Dizziness
  9. Emotional distress
  10. Eye disorder

What are the common drug interactions of Elocon and Ezetimibe, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Cross sensitivity reaction
  2. Nausea (feeling of having an urge to vomit)
  3. Vomiting

50-59:

  1. Acute myocardial infarction (acute heart attack)
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Anxiety
  4. Bone loss
  5. Emotional distress
  6. Malaise (a feeling of general discomfort or uneasiness)
  7. Osteoporosis (bones weak and more likely to break)
  8. Pain
  9. Tooth loss

60+:

  1. Klebsiella infection
  2. Dizziness
  3. Renal failure (kidney dysfunction)
  4. Renal impairment (severely reduced kidney function)
  5. Syncope (loss of consciousness with an inability to maintain postural tone)
  6. Urinary incontinence (inability to control the flow of urine and involuntary urination)
  7. Asterixis (flapping tremor, or liver flap)
  8. Balance disorder
  9. Bradycardia (abnormally slow heart action)
  10. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)

What are the existing conditions these people have? *

  1. Primary Progressive Multiple Sclerosis (primary progressive inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 3 people, 18.75%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 12.50%
  3. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 12.50%
  4. Weight Loss: 1 person, 6.25%
  5. Trigeminal Neuralgia (a painful condition of the nerve responsible for most facial sensation): 1 person, 6.25%
  6. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 6.25%
  7. Rashes (redness): 1 person, 6.25%
  8. Psoriasis (immune-mediated disease that affects the skin): 1 person, 6.25%
  9. Post Herpetic Neuralgia (neuralgia caused by the varicella zoster virus): 1 person, 6.25%
  10. Pain: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Elocon and Ezetimibe?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Elocon and Ezetimibe:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Elocon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ezetimibe:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Elocon and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ezetimibe and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on mometasone furoate and ezetimibe (the active ingredients of Elocon and Ezetimibe, respectively), and Elocon and Ezetimibe (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: